During the past decade, National Hospital Organization Osaka National Hospital conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 23 clinical trials were completed, i.e. on average, 46% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 16 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Osaka National Hospital" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Pfizer" with 5 trials sponsored, "Bayer" with 4 trials sponsored and "Daiichi Sankyo, Inc." with 4 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Osaka National Hospital" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 5 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Breast International Group" with 3 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 3 trials as a collaborator and "Japan Agency for Medical Research and Development" with 2 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Osaka National Hospital" are "Breast Cancer" (10 trials), "Breast Neoplasms" (5 trials), "Lung Cancer" (4 trials), "Colorectal Cancer" (3 trials) and "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "National Hospital Organization Osaka National Hospital" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Osaka National Hospital" are "Drug" (61 trials), "Biological" (6 trials), "Other" (6 trials), "Procedure" (5 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Paclitaxel" (4 trials), "Palbociclib" (4 trials), "Capecitabine" (3 trials) and "Abemaciclib" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Osaka National Hospital" are 66 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "National Hospital Organization Osaka National Hospital". undefined are not yet recruiting, 12 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in National Hospital Organization Osaka National Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Osaka National Hospital, 5 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".